Digital Content 
NEWS #PharmaBuzz
09 Jul 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-9-2025-1119.pdf
02 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/02/3109115/0/en/PharmaTher-Announces-Path-to-Ketamine-Commercialization-with-No-Planned-Financing-Confirms-FDA-Approval-Goal-Date-of-August-9th-2025-for-Ketamine.html
02 Jul 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-2-2025-91897.pdf
24 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/24/3104168/0/en/PharmaTher-Secures-Key-US-Patent-for-Ketamine-in-Amyotrophic-Lateral-Sclerosis-ALS-Bolstering-its-Orphan-Drug-Designated-Program-and-Targeting-a-Billion-Dollar-Market.html
23 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-announces-filing-of-commissioners-national-priority-voucher-application-for-intravenous-ketamine-nrx-100-302487956.html
05 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-files-abbreviated-new-drug-application-anda-for-preservative-free-iv-ketamine-302474014.html
Share 